An efficacious and cost-effective pharmacologic treatment for helicobacter pylori

Sarah Gurney, Laura Carvalho, Carrie Gonzalez, Esperanza Galaviz, Frances Sonstein

    Research output: Contribution to journalArticlepeer-review

    1 Scopus citations


    Helicobacter pylori (H.pylori) is a common widespread infection that, if left untreated, is a risk factor for gastric cancer. H.pylori is a contagious disease with a high prevalence in low socioeconomic areas. The multidrug regimen for eradication of H.pylori can be difficult to complete because of medication side effects, confusing dosing regimens, and cost. Thisarticle reviews H.pylori infection pathophysiology, symptoms, screening, and diagnosis. Using the most recent evidence-based research, recommendations have been made toachieve the most efficacious and cost-effective treatment of H.pylori in the primary care setting.

    Original languageEnglish (US)
    Pages (from-to)22-29
    Number of pages8
    JournalJournal for Nurse Practitioners
    Issue number1
    StatePublished - Jan 2014


    • Allergic
    • Cost-effective
    • Eradication
    • Helicobacter pylori
    • Treatment

    ASJC Scopus subject areas

    • Advanced and Specialized Nursing


    Dive into the research topics of 'An efficacious and cost-effective pharmacologic treatment for helicobacter pylori'. Together they form a unique fingerprint.

    Cite this